SCHEMBL3578284

SCHEMBL3578284

COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCN1CCCC1

nearest known ligand 0.98

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 15/20 0.98
▸ EGFR P00533 13/20 0.98
▸ AURKB Q96GD4 6/20 0.80
▸ AURKA O14965 2/20 0.80
▸ ROCK2 O75116 1/20 0.80
▸ ALDH1A1 P00352 1/20 0.80
▸ LCK P06239 1/20 0.80
▸ FYN P06241 1/20 0.80
▸ RET P07949 1/20 0.80
▸ MET P08581 1/20 0.80
▸ MAPT P10636 1/20 0.80
▸ SRC P12931 1/20 0.80
▸ PDGFRA P16234 1/20 0.80
▸ LTK P29376 1/20 0.80
▸ TTK P33981 1/20 0.80
▸ MAP2K2 P36507 1/20 0.80
▸ MAP2K1 Q02750 1/20 0.80
▸ BTK Q06187 1/20 0.80
▸ TYRO3 Q06418 1/20 0.80
▸ TNK2 Q07912 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29377224 0.89 EGFR (1.00) KDREGFRAURKBAURKAROCK2
SCHEMBL597105 0.89 EGFR (1.00) KDREGFRAURKBAURKAROCK2
SCHEMBL3530823 0.87 AURKB (1.00) KDREGFRAURKBAURKAROCK2
Anilinoquinazoline1 SCHEMBL30195580 0.87 AURKB (1.00) KDREGFRAURKBAURKAIRAK4
Anilinoquinazoline1 SCHEMBL1066538 0.87 AURKB (1.00) KDREGFRAURKBAURKAIRAK4
SCHEMBL13341789 0.86 AURKB (0.84) KDREGFRAURKBAURKAROCK2
SCHEMBL3534088 0.86 AURKB (0.84) KDREGFRAURKBAURKAROCK2
SCHEMBL3525693 0.86 AURKB (0.84) KDREGFRAURKBAURKAROCK2
Anilinoquinazoline1 SCHEMBL3968007 0.86 AURKB (0.98) KDREGFRAURKBAURKAIRAK4
SCHEMBL13341790 0.85 AURKB (0.83) KDREGFRAURKBAURKAROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709479-B1 Quinazoline derivatives and their use as pharmaceuticals ASTRAZENECA (SE) 2010-05-04 — — US disclosed
EP-1218354-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS AstraZeneca AB (SE) 2002-07-03 — — EP disclosed
WO-2001021596-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS ASTRAZENECA AB (SE) 2001-03-29 — — WO disclosed
Send feedback